These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17695516)

  • 41. Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis.
    Ueda J; Semba S; Chiba H; Sawada N; Seo Y; Kasuga M; Yokozaki H
    Pathobiology; 2007; 74(1):32-41. PubMed ID: 17496431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Akihito N; Nagano Y; Fujii S; Kunisaki C; Wada N; Rino Y; Tanaka K; Masuda M; Imada T
    Int J Oncol; 2008 Sep; 33(3):573-7. PubMed ID: 18695888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma.
    Junking M; Wongkham C; Sripa B; Sawanyawisuth K; Araki N; Wongkham S
    Eur J Cancer; 2008 Mar; 44(4):619-26. PubMed ID: 18272359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
    BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Over-expression of 14-3-3sigma in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C.
    Ide M; Saito K; Tsutsumi S; Tsuboi K; Yamaguchi S; Asao T; Kuwano H; Nakajima T
    Oncol Rep; 2007 Dec; 18(6):1451-6. PubMed ID: 17982629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro.
    O'Driscoll L; Linehan R; Liang YH; Joyce H; Oglesby I; Clynes M
    Anticancer Res; 2002; 22(6A):3117-25. PubMed ID: 12530054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fas ligand expression is a risk factor for liver metastasis in colorectal cancer with venous invasion.
    Yokomizo H; Yoshimatsu K; Ishibashi K; Hashimoto M; Yosida K; Kato H; Naritaka Y; Okada Y; Ogawa K
    Anticancer Res; 2003; 23(6D):5221-4. PubMed ID: 14981993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Proteome study of colorectal cancer genesis and hepatic metastasis].
    Bai X; Li SY; An P; Yu B; Cai HY
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2128-31. PubMed ID: 16313824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study on relationship between intratumoral DNA heterogeneity and clinicopathological findings in colorectal cancer].
    Funahashi K; Tsujita K; Miki T; Koike J; Takatsuki M; Kubota S; Watanabe M; Yanagita K; Yoshio T
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():47-51. PubMed ID: 8203930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor doubling time and local immune response to hepatic metastases from colorectal cancer.
    Kito A; Tanaka K; Fujimaki H; Nakazawa M; Togo S; Minami M; Shimada H
    J Surg Oncol; 2007 Nov; 96(6):525-33. PubMed ID: 17654526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Tumor proliferation and apoptosis after preoperative hepatic and regional arterial infusion chemotherapy in prevention of liver metastasis after colorectal cancer surgery].
    Zhong YS; Lü SX; Xu JM
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(16):1229-33. PubMed ID: 19094597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients).
    Arfaoui-Toumi A; Kria-Ben Mahmoud L; Ben Hmida M; Khalfallah MT; Regaya-Mzabi S; Bouraoui S
    Bull Cancer; 2010 Feb; 97(2):E1-8. PubMed ID: 20080461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression.
    Hörkkö TT; Klintrup K; Mäkinen JM; Näpänkangas JB; Tuominen HJ; Mäkelä J; Karttunen TJ; Mäkinen MJ
    Eur J Cancer; 2006 May; 42(7):964-71. PubMed ID: 16563744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Proteome study of colorectal cancer genesis and hepatic metastasis].
    An P; Yu B; Li SY; Zhang YN; Cai HY
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):668-71. PubMed ID: 15329256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-species comparison of biological themes and underlying genes on a global gene expression scale in a mouse model of colorectal liver metastasis and in clinical specimens.
    Bandapalli OR; Kahlert C; Hellstern V; Galindo L; Schirmacher P; Weitz J; Brand K
    BMC Genomics; 2008 Sep; 9():448. PubMed ID: 18823562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
    Noike T; Miwa S; Soeda J; Kobayashi A; Miyagawa S
    Hum Pathol; 2008 Feb; 39(2):201-8. PubMed ID: 17949784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis.
    Kuniyasu H; Oue N; Shigeishi H; Ito R; Kato Y; Yokozaki H; Yasui W
    J Exp Clin Cancer Res; 2001 Dec; 20(4):543-8. PubMed ID: 11876549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.